this post was submitted on 22 Dec 2023
264 points (97.5% liked)

Technology

59385 readers
932 users here now

This is a most excellent place for technology news and articles.

Our Rules

  1. Follow the lemmy.world rules.
  2. Only tech related content.
  3. Be excellent to each another!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, to ask if your bot can be added please contact us.
  9. Check for duplicates before posting, duplicates may be removed

Approved Bots

founded 1 year ago
MODERATORS
L3s@lemmy.world
L3s@fry.gs
L4s@fry.gs
L4s@lemmy.world
enu@lemmy.world
264
Scientists discover the first new antibiotics in over 60 years using AI (www.euronews.com)
submitted 10 months ago by L4s@lemmy.world to c/technology@lemmy.world
8 comments fedilink hide all child comments
 

Scientists discover the first new antibiotics in over 60 years using AI::A new class of antibiotics for drug-resistant Staphylococcus aureus (MRSA) bacteria which was discovered using more transparent deep learning models.

you are viewing a single comment's thread
view the rest of the comments
[–] jasory@programming.dev 0 points 10 months ago (1 children)

Antibiotics one of the most prescribed and mass produced medicines in the world (short of possibly NSAIDs), doesn't make any one money. There is absolutely no market incentive whatsoever.

You know it's not necessary to lie about basic facts, if you don't like capitalism there is much better points to criticise that don't need to be fabricated.

[–] assa123@lemmy.world 3 points 10 months ago (1 children)

Isn't that exactly what roofuskit said? Sorry to ask but, where's the lie?

[–] jasory@programming.dev 1 points 10 months ago

The first sentence was sarcasm. How does a company mass produce something that makes no money?

Financially illiterate people seem to be under the impression that rare treatments with high markup are the fiscal bedrock of pharmaceuticals when the reality is that smaller profit but mass produced medicines comprise far greater total income.